Overzicht artikelen
Hier vindt u een overzicht van wetenschappelijke artikelen geschreven naar aanleiding van of als eindproduct van projecten waarvan een teamlid van Pallas (mede)auteur is. De artikelen zijn gepubliceerd in internationale en Nederlandse tijdschriften.
2021 2020 2019 2018 2017 2016 2015 2013 - 2012 2011 2010 - 2002 Boek
2022
Bunge, E. M., Hoet, B., Chen, L., Lienert, F., Weidenthaler, H., Baer, L. R., & Steffen, R. (2022). The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS Neglected Tropical Diseases, 16(2), e0010141.
Anouk Oordt, Femke van Kessel, Eveline Bunge, Irene Santi, Ingelin Kvamme, Simone Huygens, Matthijs Versteegh. Sedative-Hypnotic Drugs for the Treatment of Primary Chronic Insomnia Disorder. HTA report. Bundesamt für Gesundheit Sektion Health Technology Assessment. January 2022
Anar Andani, Robert Steffen, Eveline Bunge, Jennifer Eeuwijk, Piyali Mukherjee, George Kassianos, Pierre Van Damme, Kassiani Mellou. Update on hepatitis A in Europe – a systematic review on outbreaks and burden of disease in 11 countries, 2001–2021. Poster presented at Viral Hepatitis Elimination Conference, Online, 24–25 February 2022: PO-140
2021
Bunge, E. M., van Hout, B., Haas, S., Spentzouris, G., & Cohen, A. Critical appraisal and issues regarding generalisability of comparative effectiveness studies of NOACs in atrial fibrillation and their relation to clinical trial data: a systematic review. BMJ open. 2021 11(2), e042024.
Andani, A., van Damme, P., Bunge, E. M., Salgado, F., van Hoorn, R. C., & Hoet, B. One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic review. Vaccine. 2021
Désirée van Oorschot, Hilde Vroling, Eveline Bunge, John Diaz-Decaro, Desmond Curran & Barbara Yawn. A systematic literature review of herpes zoster incidence worldwide. Human Vaccines & Immunotherapeutics, 1-19. 2021.
Anouk Oordt, Jennifer Eeuwijk, Eveline Bunge, Valérie Wester, Philip Klein, Tim Kanters, Carin Uyl-de Groot. Medical cannabis for treating various symptoms in Switzerland. HTA report. Bundesamt für Gesundheit Sektion Health Technology Assessment. April 2021
Desmond Curran, Andrea Callegaro, Kyle Fahrbach, Binod Neupane, Hilde Vroling, Désirée van Oorschot, Barbara P. Yawn. Meta-Regression of Herpes Zoster Incidence Worldwide. Infectious Diseases and Therapy. 10.1007/s40121-021-00567-8
Anouk Oordt, Femke van Kessel, Eveline Bunge, Irene Santi, Ingelin Kvamme, Simone Huygens, Matthijs Versteegh. Sedative-Hypnotic Drugs for the treatment of Primary Chronic Insomnia Disorder. HTA scoping report.Bundesamt für Gesundheit Sektion Health Technology Assessment. June 2021
Anouk Oordt, Femke van Kessel, Eveline Bunge, Remziye Zaim, Frederick Thielen, Philip Klein, Matthijs Versteegh. Levothyroxine for patients diagnosed with subclinical hypothyroidism. HTA protocol. Bundesamt für Gesundheit Sektion Health Technology Assessment. August 2021
Anouk Oordt, Femke van Kessel, Eveline Bunge, Remziye Zaim, Ingelin Kvamme, Matthijs Versteegh. Thyroid function tests for the diagnosis of suspected primary or secondary thyroid dysfunction. HTA protocol. Bundesamt für Gesundheit Sektion Health Technology Assessment. September 2021
Alp Giray Dogu, Anouk M. Oordt‑Speets, Femke van Kessel‑de Bruijn, Mehmet Ceyhan and
Amine Amiche. Systematic review of invasive meningococcal disease epidemiology in the Eastern Mediterranean and North Africa region. BMC Infect Dis (2021) 21:1088
Whelan J, Eeuwijk J, Bunge E, Beck E. Systematic Literature Review and Quantitative Analysis of Health Problems Associated with Sexually Transmitted Neisseria gonorrhoeae Infection. Infect Dis Ther. 2021 Dec;10(4):1887-1905. doi: 10.1007/s40121-021-00481-z. Epub 2021 Jul 17. PMID: 34279817; PMCID: PMC8572915.
2020
Anouk Oordt, Eveline Bunge, Philip Klein, Simone Huygens, Matthijs Versteegh, Nasuh Buyukkaramikli, Ken Redekop. Statins for primary prevention of cardiovascular events and mortality in Switzerland - HTA scoping report. Bundesamt für Gesundheit Sektion Health Technology Assessment. March 2020
Pamela K. Foreman, Femke van Kessel, Rosa van Hoorn, Judith van den Bosch, Renée Shediac, Sarah Landis. Birth prevalence of achondroplasia: A systematic literature review and meta-analysis. American Journal of Medical Genetics Part A.
Walid Kandeil, Caroline van den Ende, Eveline M Bunge, Victoria A Jenkins, Maria Angeles Ceregido, Adrienne Guignard. A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis. Expert Rev Vaccines. 2020 Jul;19(7):621-638.
Nasuh Buyukkaramikli, Katharina Abraham, Hilde Vroling, Eveline Bunge, Edoardo Pennesi, Maiwenn Al, Matthijs Versteegh, Anouk Oordt. Treatment of non-erosive gastroesophageal reflux disease patients with proton pump inhibitor therapy. HTA report. Bundesamt für Gesundheit Sektion Health Technology Assessment. 12 June 2020
Andani A, van Elten TM, Bunge EM, Marano C, Salgado F, Jacobsen KH. Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review. Expert Rev Vaccines. 2020 Sep 21:1-11. Online ahead of print.
Anouk Oordt, Jennifer Eeuwijk, Eveline Bunge, Valérie Wester, Philip Klein, Tim Kanters, Carin Uyl-de Groot. Medical cannabis for treating various symptoms in Switzerland. Scoping report. Bundesamt für Gesundheit Sektion Health Technology Assessment. 2 October 2020
van Giessen A, de Wit A et al. (including Eeuwijk J, van den Ende C) Impact van de eerste COVID-19 golf op de reguliere zorg en gezondheid : Inventarisatie van de omvang van het probleem en eerste schatting van gezondheidseffecten. 2020, Rijksinstituut voor Volksgezondheid en Milieu (RIVM): Bilthoven
Hulshof, TA, de Bekker, A, Verweij, A, Baâdoudi, F, Bauer, F, de Bruin-Kooistra, M, Eeuwijk, J, van den Brink, CL. Monitor cliëntondersteuning 2020: cijfers en ervaringen. RIVM rapport 2021-0017. Rijksinstituut voor Volksgezondheid en Milieu RIVM. Bilthoven. 2021
2019
Van Kessel F, Van den Ende C, Oordt-Speets AM, Kyaw MH. Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review. J Glob Health 2019; Jun:9(1):010411.
Rosales-Klintz S, Bruchfeld J, Haas W, Heldal E, Houben RMGJ, van Kessel F, Mandelbaum M, Matteelli A, Migliori GB, Oordt-Speets A, Solovic I, Vašáková M, Verver S, de Vlas SJ, Vonk Noordegraaf-Schouten MJM, de Vries G, Zenner D, van der Werf MJ. Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area. Eur Respir J. 2019;53:1802077.
Madeddu, G., Vroling, H., Oordt-Speets, A., Babudieri, S., O'Moore, É., Noordegraaf, M. V., ... & Tavoschi, L.. Vaccinations in prison settings: a systematic review to assess the situation in EU/EEA countries and in other high income countries. Vaccine; 2019
Tavoschi, L., O'Moore, É., & Hedrich, D. Challenges and opportunities for the management of infectious diseases in Europes' prisons: evidence-based guidance. The Lancet Infectious Diseases; 2019
Anouk Oordt, Eveline Bunge, Katharina Abraham, Maiwenn Al, Matthijs Versteegh, Nasuh Buyukkaramikli. Treatment of non-erosive gastroesophageal reflux disease patients with proton pump inhibitors - HTA scoping report. Bundesamt für Gesundheit Sektion Health Technology Assessment. September 2019
2018
Eeuwijk J, Vonk Noordegraaf-Schouten M. Onderzoeksagenda infectieziektebestrijding. Den Haag: ZonMw; 2018.
Willame C, Vonk Noordegraaf-Schouten M, Gvozdenović E, Kochems K, Oordt-Speets A, Praet N, Van Hoorn R, Rosillon D. Effectiveness of the oral human attenuated rotavirus vaccine: a systematic review and meta-analysis-2006-2016. Open Forum Infect Dis. 2018;5(11).
European Centre for Disease Prevention and Control. Review of reviews and guidelines on target groups, diagnosis, treatment and programmatic issues for implementation of latent tuberculosis management. Stockholm: ECDC; 2018 (Pallas authors: Femke van Kessel, Anouk Oordt-Speets and Marije Vonk Noordegraaf-Schouten)
DeAntonio R, Amador S, Bunge EM, Eeuwijk J, Prado-Cohrs D, Nieto Guevara J, Rubio MDP, Ortega-Barria E. Vaccination herd effect experience in Latin America: a systematic literature review. Hum Vaccin Immunother. 2018:1-23. [Epub ahead of print]
Vroling H, Oordt-Speets AM, Madeddu G, Babudieri S, Monarca R, O'Moore E, Vonk Noordegraaf-Schouten M, Wolff H, Montanari M, Hedrich D, Tavoschi L. A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA. J Viral Hepat. 2018;25(12):1406-22.
Oordt-Speets AM, Bolijn R, Van Hoorn RC, Bhavsar A, Kyaw MH. Global etiology of bacterial meningitis: A systematic review and meta-analysis. Plos ONE 2018.
Olij B, Polinder S, Erasmus V, Smilde D. Valpreventie-activiteiten bij ouderen in Nederland: Een Delphi-studie onder zorgverleners uit de eerste lijn. Nederlands Tijdschr Geriatriefysioth 2018;32(1):31-37.
Tavoschi L, Vroling H, Madeddu G, Babudieri S, Monarca R, Vonk Noordegraaf-Schouten M, Beer N, Gomes Dias J, O’Moore E, Hedrich D, Oordt-Speets A. Active case finding for communicable diseases in prison settings: increasing testing coverage and uptake among the prison population in the EU/EEA. Epidemiologic Reviews 2018; Apr 10.
2017
Galgani I, Bunge EM, Hendriks L, Schludermann C, Marano C, De Moerlooze L. Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedules. Expert Rev Vaccines 2017;16:919-32.
Younossi Z, Kochems K, de Ridder M, Curran D, Bunge EM, de Moerlooze L. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease. Hum Vaccin Immunother 2017;13:2695-2706.
Stuurman AL, Marano C, Bunge EM, De Moerlooze L, Shouval D. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review. Hum Vaccin Immunother 2017;13:724-36. Review.
Van den Ende C, Marano C, van Ahee A, Bunge EM, De Moerlooze L. The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience. Expert Rev Vaccines 2017;16(8):789-809.
Van den Ende C, Marano C, Van Ahee A, Bunge EM, De Moerlooze L. The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience. Expert Rev Vaccines 2017;16(8):811-32.
Varghese L, Curran D, Bunge E, Vroling H, van Kessel F, Guignard A, Casabona G, Olivieri A. Contraindication of live vaccines in immunocompromised patients: an estimate of the number of affected people in the USA and the UK. Public Health 2017;142:46-9.
2016
Bakker M, Bunge EM, Marano C, de Ridder M, De Moerlooze L. Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review. Expert Rev Vaccines 2016;15:829-51.
Sandgren A, Vonk Noordegraaf-Schouten JM, Oordt-Speets AM, van Kessel GB, de Vlas SJ, van der Werf MJ. Identifying components for programmatic latent tuberculosis infection control in the European Union. Euro Surveill 2016;25:21(34).
Sandgren A, Vonk Noordegraaf-Schouten M, van Kessel F, Stuurman A, Oordt-Speets A, van der Werf MJ. Initiation and completion rates for latent tuberculosis infection treatment: a systematic review. BMC Infect Dis 2016;16:204.
Stuurman AL, Vonk Noordegraaf-Schouten M, van Kessel F, Oordt-Speets AM, Sandgren A, van der Werf MJ. Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review. BMC Infect Dis 2016;16:257.
Tafallaa M, Buijssen M, Geetsa R, Vonk Noordegraaf-Schouten M. A comprehensive review of the epidemiology and disease burden of Influenza B in nine European countries. Human Vaccines & Immunotherapeutics 2016;12:993-1002.
Taylor S, Bunge E, Bakker M, Castellsagué X. The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature. BMC Infect Dis 2016;16:293.
Willame C, Rosillon D, Zima J, Angelo MG, Stuurman AL, Vroling H, Boggon R, Bunge EM, Pladevall-Vila M, Baril L. Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Hum Vaccin Immunother 2016;12:2862-71.
Oeseburg B, Schols J, Olde Rikkert M, van der Horst H, Smilde-van den Doel D, de Rooij S, Buurman-van Es B, Schuurmans M, Gussekloo J. Onderwijs in het Nationaal Programma Ouderenzorg. Tijdschr Gerontol Geriatr. 2016;47:272-81.
Willame C, Baril L, Van den Bosch J, Ferreira GLC, Williams R, Rosillon D, Cohet C. Importance of feasibility assessments before implementing non-interventional pharmacoepidemiologic studies of vaccines: lessons learned and recommendations for future studies. Pharmacoepidemiology and drug safety 2016;25:1397-1406.
2015
Baril L, Rosillon D, Willame C, Angelo MG, Zima J, van den Bosch JH, Van Staa T, Boggon R, Bunge EM, Hernandez-Diaz S, Chambers CD. Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Vaccine 2015;33:6884-91.
Eeuwijk J, Van den Bosch JH, Van der Wal G, Robben P. Met de wijsheid achteraf. Hindsight en outcome bias in het toezicht. Tijdschrift voor Toezicht 2015;3:6-20.
Getahun H, et al. (met o.a. Van Kessel F, Oordt-Speets A en Vonk Noordegraaf-Schouten M). Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 2015;46:1563-76.
Van den Bosch JH, Warren DS, Rutherford PA. Review of predialysis education programs: a need for standardization. Patients Preference Adherence 2015;9:1279-91.
2012 - 2013
Steens A, Wielders CC, Bogaards JA, Boshuizen HC, de Greeff SC, de Melker HE. Association between human papillomavirus vaccine uptake and cervical cancer screening in the Netherlands: Implications for future impact on prevention. Int J Cancer 2013;132:932-43.
Snijders BE, Lier AV, van de Kassteele J, Fanoy EB, Ruijs WL, Hulshof F, Blauwhof A, Schipper M, van Binnendijk R, Boot HJ, de Melker HE, Hahné SJ. Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008. Vaccine 2012;30:2999-3002.
Wielders CC, van Lier EA, van 't Klooster TM, van Gageldonk-Lafeber AB, van den Wijngaard CC, Haagsma JA, Donker GA, Meijer A, van der Hoek W, Lugnér AK, Kretzschmar ME, van der Sande MA. The burden of 2009 pandemic influenza A(H1N1) in the Netherlands. Eur J Public Health 2012;22:150-7.
2011
Donker T, van Boven M, van Ballegooijen WM, Van 't Klooster TM, Wielders CC, Wallinga J. Nowcasting pandemic influenza A/H1N1 2009 hospitalizations in the Netherlands. Eur J Epidemiol 2011;26:195-201.
Speets AM, Wolleswinkel JH, Cardoso CI. Societal costs and burden of otitis media in Portugal. Journal of Multidisciplinary Healthcare 2011;4:53-62.
Speets AM, Wolleswinkel JH, Forsgren A, Sobocki PA. Use of medical resources and indirect costs of otitis media in Sweden. Scandinavian Journal of Public Health. 2011;39:137-46.
Wielders CC, van Binnendijk RS, Snijders BE, Tipples GA, Cremer J, Fanoy E, Dolman S, Ruijs WL, Boot HJ, de Melker HE, Hahné SJ. Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009. Eurosurveillance 2011;16:1-9.
Wolleswinkel-van den Bosch JH, Speets AM, Rümke HC, Gumbs PD, Fortanier SC. The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey. BMC Infectious Diseases 2011;11:320.
2002 - 2010
Wolleswinkel-van den Bosch JH, Stolk EA, Francois M, Gasparini R, Brosa M. The health care burden and societal impact of acute otitis media in seven European countries: Results of an Internet survey. Vaccine 2010;28S:G39-G52.
Ariëns GAM, Snijders BEP, Berns MPH, Van der Leeuw-van Someren PA, Zwartendijk-Schats MATW. Nieuwe cijfers over roken, drinken, drugsgebruik en gokken onder Haagse scholieren. Epidemiologisch bulletin 2009;44:11-21.
Van 't Klooster TM, Wielders CC, Donker T, Isken L, Meijer A, van den Wijngaard CC, van der Sande MA, van der Hoek W. Surveillance of Hospitalisations for 2009 Pandemic Influenza A(H1N1) in the Netherlands, 5 June – 31 December 2009. Euro Surveill 2010;15:pii=19461.
Vonk Noordegraaf Marije, Smilde Dini. GHOR: organisatie en inhoud samengevat. TSG 2009;7:282-4.
Ariëns GAM, Middelkoop BJC, Smilde-van den Doel DA, Struben HWA. Gezondheidsvragen in de Stadsenquête Den Haag 2001 en 2003; de uitkomsten bekeken in relatie tot etnische achtergrond en opleidingsniveau. Epidemiologisch bulletin 2006;41:2-11.
Desselberger U, Wolleswinkel-van den Bosch J, Mrukowicz J, Rodrigo C, Giaquinto C, Vesikari T. Rotavirus types in Europe and their significance for vaccination. Pediatr Infect Dis J 2006;25:S30-41. Review.
Huppertz HI, Soriano-Gabarro M, Grimprel E, Franco E, Mezner Z, Desselberger U, Smit Y, Wolleswinkel-van den Bosch J, De Vos B, Giaquinto C. Intussusception among young children in Europe. Pediatr Infect Dis J 2006;25:S22-9.
Linhares AC, Verstraeten T, Wolleswinkel-van den Bosch J, Clemens R, Breuer T. Rotavirus serotype G9 is associated with more-severe disease in Latin America. Clin Infect Dis 2006;43:312-4.
Smilde-van den Doel DA, Smit C, Wolleswinkel-van den Bosch JH. School performance and social-emotional behavior of primary school children before and after a disaster. Pediatrics 2006;118:e1311-20.
The Pediatric ROTavirus European CommitTee (PROTECT). The paediatric burden of rotavirus disease in Europe. Epidemiol Infect 2006;134:908-16. Review. (JH Wolleswinkel member of PROTECT writing committee).
Aaldriks AA, Wolleswinkel-van den Bosch JH, Mackenbach JP. Substandaardfactoren in de verloskundige eerstelijnszorg. Ned Tijdschr Geneeskd 2005;149:1334-8.
Van Nooijen Kooij GAM, Wolleswinkel-van den Bosch JH. Verwerkingsproblemen bij jongeren na de cafébrand in Volendam. Tijdschrift voor Jeugdgezondheidszorg 2005;37:82-87.
Van Poppel F, Deerenberg I, Wolleswinkel-van den Bosch J, Ekamper P. Hoe lang leefden wij? Historische veranderingen in de levensduur en het doodsoorzakenpatroon. Bevolkingstrends. Statistisch kwartaalblad over de demografie van Nederland. Jaargang 53 - 3e kwartaal 2005. Heerlen/Voorburg, 2005.
Amelink-Verburg MP, van Roosmalen J, Roelofsen JM, Wolleswinkel-van den Bosch JH, Verloove-Vanhorick SP. Evaluatie en validatie van perinatale sterfte audit via terugkoppeling naar zorggevers. Ned Tijdschr Geneeskd 2003;147:2333-7.
Wolleswinkel-van den Bosch JH, Nagelkerke NJ, Broekmans JF, Borgdorff MW. The impact of immigration on the elimination of tuberculosis in The Netherlands: a model based approach. Int J Tuberc Lung Dis 2002;6:130-6.
Boek(hoofdstuk)
Te Brake Hans HM, Kellert Ira, Wolleswinkel-van den Bosch Judith. Stressreacties bij traumahulpverlening: risico van het vak? In: Zwarthoed Yvonne. Help, ik heb geholpen. Amsterdam: Impact, 2010, p 58-103.
Vonk Noordegraaf-Schouten Marije en Smilde van den Doel Dini (red.). Topinstituut Gezond Ouder worden. Conferentie 27 oktober 2008. Leiden: Leids Universitair Medisch Centrum, 2009, 92 pagina’s.
Wolleswinkel Judith, Smilde Dini, Van der Heide Agnes. Overwegingen bij de financiering van vruchtbaarheidsbehandelingen. De mening van deskundigen en de Nederlandse bevolking. In: Den Hartogh Govert, De Beaufort Inez (red.). Een hoge prijs voor een kind. Morele problemen van nieuwe reproductieve technologieën, Assen: Van Gorcum, Reeks 'Gezondheidsethiek' no. 13, 2006, p 44-62.
Op de hoogte blijven?
Meld u dan aan voor onze nieuwsbrief. We houden u een aantal maal per jaar op de hoogte van recente projecten en ontwikkelingen.
Social Media
Blijf op de hoogte door ons te volgen!
Contact
Millennium Tower
Unit 26.18 of 26.17
Weena 690
3012 CN Rotterdam
Door de huidige situatie met het coronavirus zijn we telefonisch slecht bereikbaar. Neem contact op per e-mail.
Telefoon +31 (0)10 447 44 49
E-mail info@pallashrc.com
